Furthermore, cathepsin G (CTSG) and Ras-related C3 botulinum toxin substrate 1 (RAC1), which are pivotal for T cell responses, FLS activation, and ROS generation, were shown to be upregulated in RA-affected joints with high and low levels of inflammation, respectively[77]. This evidence concerns the gene RAC1 and rheumatoid arthritis.